Minor
Established
説明
Fluconazole has minimal effect on pravastatin exposure because pravastatin is not significantly metabolised by CYP enzymes; the interaction is pharmacokinetically unimportant in most patients.
機序
Unlike most statins, pravastatin relies on renal and biliary excretion rather than CYP3A4 metabolism; fluconazole's CYP inhibition does not substantially affect pravastatin clearance.
臨床的意義
Pharmacokinetic studies confirm no clinically significant increase in pravastatin AUC with fluconazole; no cases of myopathy attributable to this combination have been reported.
対処法
No dose adjustment required; this combination is generally preferred over other statin-azole combinations.